It’s been a busy week so far in our industry! International Clinical Trials Day, an AstraZeneca update and we continue our discussion on the importance of diversity in Clinical Trials.
1. Did you know yesterday was International Clinical Trials Day? Do you know the meaning behind it? How did you celebrate?
2. IT’S JUST NOT GONNA HAPPEN! AstraZeneca turned down Pfizer on what is claimed to be their final bid. The bid, worth about $119 billion, led AstraZeneca to declare that the bid “undervalues the company and its attractive prospects.”
3. As you know, we are closely following the discussion on diversity in Clinical Trials, (please take a look at our previous blog post). A recent article we found, discusses how Hispanic enrollment is crucial to cancer clinical trials.